Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location

Kidney Disease Clinical Trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (474) clinical trials

The study drug (vadadustat) is an investigational drug. This potential new drug is being tested to treat anemia (low red blood cell count) in patients with chronic (long-term) kidney disease. This is a Phase 3 study, which means that the study drug has already been tested in other studies involving ...

Phase N/A

The study drug (vadadustat) is an investigational drug. This potential new drug is being tested to treat anemia (low red blood cell count) in patients with chronic (long-term) kidney disease. This is a Phase 3 study, which means that the study drug has already been tested in other studies involving ...

Phase N/A

A research study is evaluating an investigational medication for kidney disease.

Phase N/A

People with hepatorenal syndrome (HRS) type 1 are asked to participate in a research study being conducted by Montefiore Medical Center.

Phase N/A

Merck is conducting a clinical research study for adults who are at least 25 years of age and have been diagnosed with type 2 diabetes. The purpose of this study is to compare the safety and effectiveness of the oral medications sitagliptin versus dapagliflozin for the treatment of type 2 ...

Phase

The purpose of the study is to evaluate a fluorescent drug for the use of a non-invasive device to measure kidney function. There are 3 scheduled study visits over about 2 months. 2 study visits will last 1 to 2 hours. The other study visit will last about 13 hours. ...

Phase N/A

Demonstrate whether, in addition to standard of care finerenone is superior to placebo in delaying the progression of kidney disease, as measured by the composite endpoint of time to first occurrence of kidney failure , a sustained decrease of eGFR ≥ 40% from baseline over at least 4 weeks or ...

Phase